Phase 1 Study to Investigate Safety, Tolerability, PK/PD of J2H-1702 in Healthy Females

Conditions: Non-alcoholic Steatohepatitis Interventions: Drug: Amg dose administration group; Drug: Amg dose administration group- Placebo; Drug: Bmg dose administration group; Drug: Bmg dose administration group- Placebo Sponsors: J2H Biotech Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials